| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Praxis Precision Medicine (NASDAQ:PRAX) through any online brokerage.
Other companies in Praxis Precision Medicine’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Praxis Precision Medicine has a consensus price target of $554.32.
The stock price for Praxis Precision Medicine (NASDAQ: PRAX) is $270.99 last updated October 21, 2026 at 5:50 AM EDT.
There are no upcoming dividends for Praxis Precision Medicine.
Praxis Precision Medicine does not have any upcoming earnings scheduled.
There is no upcoming split for Praxis Precision Medicine.
Praxis Precision Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
